Experienced in Anaplastic Large Cell Lymphoma

Dr. Nicole Gormley

Intensive Care Medicine
Molecular Medicine And Neuroscience
10 Center Dr Bldg 10, 
Bethesda, MD 
Experienced in Anaplastic Large Cell Lymphoma
Molecular Medicine And Neuroscience
10 Center Dr Bldg 10, 
Bethesda, MD 
OverviewInsuranceLocationsClinical Research

Overview

Nicole Gormley is an Intensive Care Medicine provider in Bethesda, Maryland. Dr. Gormley is rated as an Experienced provider by MediFind in the treatment of Anaplastic Large Cell Lymphoma. Her top areas of expertise are Multiple Myeloma, Aplastic Anemia, Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, and Bone Marrow Transplant.

Her clinical research consists of co-authoring 49 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Anaplastic Large Cell Lymphoma.

Specialties
Intensive Care Medicine
Licenses
Critical Care Medicine in MD
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO

Locations

Molecular Medicine and Neuroscience
10 Center Dr Bldg 10, Bethesda, MD 20892

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

49 Total Publications

US Food and Drug Administration Approval Summary: Ribociclib With an Aromatase Inhibitor in the Adjuvant Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Stage II and III High-Risk Early Breast Cancer Treatment Setting.
US Food and Drug Administration Approval Summary: Ribociclib With an Aromatase Inhibitor in the Adjuvant Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Stage II and III High-Risk Early Breast Cancer Treatment Setting.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gormley's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile